MOS
CORT icon

MGO One Seven’s Corcept Therapeutics CORT Stock Holding History

MGO One Seven’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,145
Closed -$249K – 1418
2025
Q4 		$249K Sell
7,145
-53
-0.7% -$4.16K 0.01% 1200
2025
Q3 		$598K Buy
7,198
+1,056
+17% +$76.4K 0.01% 754
2025
Q2 		$451K Sell
6,142
-551
-8% -$39.9K 0.01% 764
2025
Q1 		$764K Buy
+6,693
New +$407K 0.03% 509
2018
Q1 		$3K Sell
159
-5,722
-97% -$106K ﹤0.01% 1428
2017
Q4 		$106K Buy
+5,881
New +$107K 0.05% 421

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

MGO One Seven's CORT Position: Q1 2026 in Review

MGO One Seven sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 7,145 shares — an estimated $249K sold.

MGO One Seven first reported a position in CORT in Q4 2017 and held it in 6 quarters. The position peaked at $764K in Q1 2025. 352 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • MGO One Seven reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • MGO One Seven sold 7,145 Corcept Therapeutics shares in Q1 2026, an estimated $249K.
  • MGO One Seven first reported a position in Corcept Therapeutics in Q4 2017 and held it in 6 quarters.
  • MGO One Seven's Corcept Therapeutics position peaked at $764K in Q1 2025.
  • 352 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on MGO One Seven's 13F filing for Q1 2026, filed 14 May 2026.